Home Tags NASDAQ:DVAX

Tag: NASDAQ:DVAX

Dynavax Technologies Corporation (NASDAQ: DVAX) And Clover Biopharmaceuticals Announces Results For...

Gavins Felicity - 0

Dynavax Technologies Corporation (NASDAQ:DVAX) Reports Record HEPLISAV-B® Vaccine Net Revenue Of...

Matt Wade - 0

Dynavax Technologies’(NASDAQ:DVAX) Appoints Peter Paradiso To Board And Its CFO To...

Gavins Felicity - 0

The Bill & Melinda Gates Foundation Grants Dynavax Technologies Corporation (NASDAQ:DVAX)...

Kate Hudson - 0

TriSalus Life Sciences Enters into an Asset Purchase Agreement under Which...

Gavins Felicity - 0
12Page 1 of 2

Recent Post

Pfizer’s (NYSE: PFE) Ponsegromab Shows Promise in Fighting Cancer Cachexia

Gavins Felicity - 0
Pfizer (NYSE: PFE) recently announced positive results from a midstage trial of their experimental drug, ponsegromab, designed to treat cancer cachexia, a...

Singular Genomics (OMIC) Receives Buyout Offer, Stock Soars

Instil Bio (TIL) Surges on Promising Cancer Therapy Licensing Deal

Summit Therapeutics Secures $235 Million in Funding from Leading Biotech Investors

Monopar Therapeutics’ (MNPR) MNPR-101-Zr Shows Promising Tumor Targeting in Early Clinical...

© BioPharma Journal 2020